Loading insider details...
Beta
Latest Form 4 (Mar 3, 2026): Exercise/Conversion of 160,237 LXRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 3, 2026 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Exercise/Conversion | 160,237 | n/a |
| Feb 17, 2026 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 272,680 | n/a |
| Feb 18, 2025 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 721,070 | n/a |
| Jan 2, 2025 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 230,000 | n/a |
| Aug 26, 2024 | AGILE THERAPEUTICS INC (AGRX) | Disposition to Issuer | 15,000 | $22.8K |
| Aug 1, 2022 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 60,800 | n/a |
| Jun 7, 2022 | Aprea Therapeutics, Inc. (APRE) | Tax Withholding | 35,284 | $28.4K |
| Mar 14, 2022 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 42,900 | n/a |
| Mar 1, 2022 | Aprea Therapeutics, Inc. (APRE) | Tax Withholding | 14,817 | $25.8K |
| Aug 27, 2021 | Aprea Therapeutics, Inc. (APRE) | Tax Withholding | 7,534 | $30.0K |